Effectiveness of RSV-IG in premature infants: Potential pitfalls in clinical settings [1]

Pediatrics

Volumn 101, Issue 2, 1998, Pages 320-321

  Seid, M ^a   Kurtin, P S ^a   Romanowski, G L ^a   Wozniak, P R ^a   Wenger, S ^a   Segota, S L ^a   Bradley, J ^a   Chan, A ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HUMAN; IMMUNOPROPHYLAXIS; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION;

EID: 0031951235     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.2.320     Document Type: Letter

References (5)